State of the Discovery Nation 2024
State of the Discovery Nation 2024 Report Reveals the Extent of Sector’s Perfect Storm The State of the Discovery Nation 2024 report by Medicines Discovery Catapult, in partnership with the UK BioIndustry Association and the Association of the British Pharmaceutical Industry, highlights the impact of recent economic instability on companies in the life sciences sector. […]
Narration of the State of the Discovery Nation 2021 Report
A new wave of medicines has emerged in recent years, to supplement the established small and large molecule platforms. These complex medicines will become as important as traditional small molecule drugs in the coming years, with market values of hundreds of billions of pounds. Hear from our CSO, Prof. Peter Simpson as he talks about […]
State of the Discovery Nation 2021
Complex medicines will become as important as traditional small molecule drugs in the coming years, with market values of hundreds of billions of pounds. Pharmaceutical and biotech companies working in complex medicines in the UK include those specialising in antibody-drug conjugates, firms developing oligonucleotide therapeutics, entities focusing on proprietary delivery technologies for a range of […]
State of the Discovery Nation 2019
The 2019 edition of the State of the Discovery Nation report by the Medicines Discovery Catapult and the BIA reveals a thriving service and supply sector for the UK in addition to its R&D biotech’s. It also highlights two breakthrough technologies set to influence the future of medicines discovery and maintain the UK’s global competitiveness. Key […]
State of the Discovery Nation 2018
The Medicines Discovery Catapult and BioIndustry Association call on the R&D community to address five themes to help boost productivity This report, based on surveys and over 100 in-depth interviews with senior executives of UK drug discovery companies, shows that global R&D productivity is under unprecedented pressure. In response to this, world leading opportunities exist […]